Inactive Instrument
Creative Antibiotics Sweden AB Stock
Stocks
CAS
SE0001136474
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq Stockholm
|
||
| - SEK | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 18/05/2010 | |
| Corporate Officer/Principal | - | 01/01/2010 | |
Charlotta Sundin
PRN | Corporate Officer/Principal | - | 18/05/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.29% | -1.76% | +51.98% | +64.66% | 66.33B | ||
| -0.09% | +2.79% | +10.75% | +95.02% | 60.62B | ||
| +0.63% | +1.64% | +24.25% | +89.70% | 55.5B | ||
| -0.96% | -1.22% | +9.45% | +117.91% | 47.58B | ||
| -0.07% | -4.92% | +22.68% | +29.47% | 43.69B | ||
| -3.06% | -16.63% | +141.34% | +685.22% | 37.27B | ||
| +0.23% | +1.66% | +14.85% | +49.06% | 36.57B | ||
| +2.35% | -3.61% | +78.64% | +60.70% | 32.22B | ||
| +1.35% | +6.10% | -37.60% | +404.03% | 26.58B | ||
| Average | -0.08% | +0.33% | +35.15% | +177.31% | 45B | |
| Weighted average by Cap. | -0.22% | +0.33% | +35.02% | +152.45% |
Employees
-
- Stock Market
- Stocks
- CAS Stock
Select your edition
All financial news and data tailored to specific country editions
















